Abortions in the Soviet Union became much more accessible under the Khrushchev administration in 1953, and the USSR's abortion rate subsequently developed into the highest in the world. The Soviet government did not begin releasing official statistical data until the 1970s, however it is believed that around six or seven million abortions were carried out each year in the 1950s and 1960s; a figure that remained fairly consistent until the late 1980s**. This high rate was, in-part, due to rapid urbanization and a desire for smaller families, as well as the lack of quality contraceptives produced by the Soviet government, and the widespread belief that abortion was safer than the side-effects of hormonal regulation via the pill. Relative to population size, there were between 97 and 106 abortions carried out per 1,000 women aged between 15 and 49 in the given years, which is roughly equal to one in ten women of childbearing age having an abortion each year (estimates for Russia alone suggest that this number was one in six in the 1960s). There were however regional disparities across the Soviet Union, as abortions were much more accessible and common in the European part of the country, and less available or socially acceptable in the Muslim-majority and rural regions of Asia. Abortion in the U.S. In the U.S. during this time, the abortion rate was much lower due to previous legal restrictions and lack of access, societal attitudes, and better access to contraceptives. Prior to 1973, abortions were either banned outright or only available under specific circumstances in all-but-four states. The Supreme Court case Roe v. Wade then saw the removal of most federal restrictions relating to abortion in the first trimester of pregnancy. This granted women across the country greater access to legal abortions; in 1975 there were over one million legal abortions performed in the U.S., and between 1.5 and 1.6 million in the 1980s. Proportional to population size, this equated to 29 abortions per 1,000 women aged between 15 and 45 in 1980, which is roughly equal to one in 34 women of childbearing age having an abortion in this year. Legacy During the decline and dissolution of the Soviet Union, the government began to promote the use of contraceptives, however the poor quality and supply of these reinforced former perceptions that they were more harmful than abortions. Additionally, medical institutions received much higher sums from the government when abortions were performed (relative to income from contraceptives), and these incentives delayed the drop in Russian and other post-Soviet states' abortion rates. While it is now generally accepted that contraception is safer than abortion, and awareness of the risks of infertility and maternal death has become more widespread, today, Soviet successor states have some of the highest abortion rates in the world by a considerable margin.

In the U.S., following the peak of almost 30 abortions per 1,000 women aged 15 to 44 in the 1980s, the abortion rate has gradually fallen with each decade, even dropping below the 1973 level in 2017. Although this is a side effect of improvements in contraception and education, a large part of this decline can be attributed to restricted access to abortion, particularly in rural and southern regions. While the majority of U.S. adults support Roe v. Wade, the Supreme Court overturned the ruling in June 2022, granting states the right to determine their own abortion laws.

In 2022, there were around 613 thousand legal abortions in the United States. The number of legal abortions in the United States has decreased significantly since the early 1990’s. This number will probably continue to decrease in the coming years since many states have severely limited or completely banned abortion after the overturning of Roe v. Wade by the Supreme Court in 2022. The states with the highest abortion rates In 2022, the rate of legal abortions per live births in the United States was 19.9 per 100. In comparison, in 1990 there were 34.4 abortions per 100 live births. The states with the highest rates of abortion per live births are New Mexico, Illinois, and Florida. In Florida, there were around 37 abortions per 100 live births in 2022. Florida had the highest total number of abortions that year, followed by New York and Illinois. Missouri and South Dakota had the lowest number of abortions in 2022. Out-of-state abortions Critics of the Supreme Court decision to overturn Roe v. Wade argue that while those who can afford it may be able to travel to other states for an abortion if their state bans the procedure, poorer residents will have no such choice. Even before the overturning of Roe v. Wade, out-of-state residents already accounted for a high share of abortions in certain states. In 2022, 69 percent of abortions in Kansas were performed on out-of-state residents, while out-of-state residents accounted for around 62 percent of abortions in New Mexico. Illinois had the highest total number of abortions performed on out-of-state residents that year, with around 16,849 procedures.

Analysis of ‘🤰 Pregnancy, Birth & Abortion Rates (1973 - 2016)’ provided by Analyst-2 (analyst-2.ai), based on source dataset retrieved from https://www.kaggle.com/yamqwe/pregnancy-birth-abortion-rates-in-the-united-stae on 13 February 2022.

--- Dataset description provided by original source is as follows ---

About this dataset

Source: OSF | Downloaded on 29 October 2020

This data source is a subset of the original data source. The data has been split by State, Metric and Age Range. It has been limited to pregnancy rate, birth rate and abortion rate per 1,000 women. The original data contains many more measures.

The data was prepared with Tableau Prep.

Summary via OSF -

A data set of comprehensive historical statistics on the incidence of pregnancy, birth and abortion for people of all reproductive ages in the United States. National statistics cover the period from 1973 to 2016, the most recent year for which comparable data are available; state-level statistics are for selected years from 1988 to 2016. For a report describing key highlights from these data, as well as a methodology appendix describing our methods of estimation and data sources used, see https://guttmacher.org/report/pregnancies-births-abortions-in-united-states-1973-2016.

​

This dataset was created by Andy Kriebel and contains around 20000 samples along with Age Range, Events Per 1,000 Women, technical information and other features such as: - State - Year - and more.

How to use this dataset

• Analyze Metric in relation to Age Range
• Study the influence of Events Per 1,000 Women on State
• More datasets

Acknowledgements

If you use this dataset in your research, please credit Andy Kriebel

Start A New Notebook!

--- Original source retains full ownership of the source dataset ---

A survey of women who obtained an abortion in the United States between June 2021 and July 2022 found that 45 percent of women who received an abortion were insured under Medicaid, while 21 percent had no health insurance at all. This statistic shows the distribution of women in the U.S. who obtained an abortion from June 2021 to July 2022, by health insurance status.

In 2022, the states with the highest rates of abortion per 1,000 women aged 15 to 44 years in the United States were New Mexico, Illinois, and Kansas. The states with the lowest rates of abortion were Missouri and South Dakota. Abortion differences among the states In 2022, the U.S. Supreme Court overturned Roe v. Wade allowing states to restrict the practice of abortion or outright ban it completely. A number of states immediately banned the procedure through trigger laws they had in place in anticipation of the ruling. Even before the ruling, abortion accessibility and rates varied greatly from state to state, but this difference has become even more pronounced. For example, in 2022, Florida had an abortion rate of 20.5 per 1,000 women, while the rate in Missouri was just .1. Florida had the highest total number of abortions that year, followed by New York and Illinois. While Florida reported around 82,581 abortions in 2022, there were just 88 such procedures in Missouri. Public opinion on abortion In the United States, the debate surrounding abortion is often divided among those who are “pro-life” and think abortion should be restricted or banned and those who are “pro-choice” and believe the decision to abort a pregnancy should be up to the woman. Gallup polls show the distribution of people in the United States who are pro-life or pro-choice has fluctuated over the years but in 2023 around 52 percent of respondents stated they were pro-choice while 44 percent said they were pro-life. Older respondents are more likely to express views limiting access to abortion, while younger people are more likely to believe abortion should be legal under any circumstance. However, just a small minority of people of all ages believe abortion should be illegal in all circumstances.

ObjectiveTo determine which characteristics and circumstances were associated with very early and second-trimester abortion.MethodsPaper and pencil surveys were collected from a national sample of 8,380 non-hospital U.S. abortion patients in 2014 and 2015. We used self-reported LMP to calculate weeks gestation; when LMP was not provided we used self-reported weeks pregnant. We constructed two dependent variables: obtaining a very early abortion, defined as six weeks gestation or earlier, and obtaining second-trimester abortion, defined as occurring at 13 weeks gestation or later. We examined associations between the two measures of gestation and a range of characteristics and circumstances, including type of abortion waiting period in the patients’ state of residence.ResultsAmong first-trimester abortion patients, characteristics that decreased the likelihood of obtaining a very early abortion include being under the age of 20, relying on financial assistance to pay for the procedure, recent exposure to two or more disruptive events and living in a state that requires in-person counseling 24–72 hours prior to the procedure. Having a college degree and early recognition of pregnancy increased the likelihood of obtaining a very early abortion. Characteristics that increased the likelihood of obtaining a second-trimester abortion include being Black, having less than a high school degree, relying on financial assistance to pay for the procedure, living 25 or more miles from the facility and late recognition of pregnancy.ConclusionsWhile the availability of financial assistance may allow women to obtain abortions they would otherwise be unable to have, it may also result in delays in accessing care. If poor women had health insurance that covered abortion services, these delays could be alleviated. Since the study period, four additional states have started requiring that women obtain in-person counseling prior to obtaining an abortion, and the increase in these laws could slow down the trend in very early abortion.

Abortion in the United States is still a contentious topic. In 2022, the leading state by number of legal abortions in the United States was Florida, which reported 82,581 abortions. In that year, New York reported 72.7 thousand abortions, followed by Illinois with almost 56.5 thousand. There were a total of almost 613,383 legal abortions in the United States in 2022.

The Data Center at the Guttmacher Institute is focused on providing information on the state, national, and international level related to reproductive and sexual health. Background The Data Center is maintained by the Guttmacher Institute. The Guttmacher Institute’s goal is to advance the sexual and reproductive health in the United States and worldwide through an interrelated program of social science research, policy analysis and public education designed to generate new ideas, encourage enlightened public debate and promote sound policy and program development. In 2009, Guttmacher was designated an official Collaborating Center for Reproductive Health by the World Health Organization and its regional office, the Pan American Health Organization. The Institute produces a wide range of publications and resources on topics pertaining to sexual and reproductive health, including International Perspectives on Sexual and Reproductive Health, the Guttmacher Policy Review and Perspectives on Sexual and Reproductive Health. The Data Center allows users to search on the national, inter national, and state level for specific laws and policies related to title X, family planning, abortion policies, contraceptive needs and services, and teen pregnancy. User functionality Users are able to search U.S. and state data as well as international data. State profiles and country summaries are provided and include synopses of the main legislation related to sexual and reproductive health in that area. Users are also able to customize domestic and international data by creating a specific table, tracking a specific trend, or generating a specific map. Users are able to select specific indicators including data related to abortions, adol escents, demographics, contraception, pregnancy, and services and financing. Data Notes Users are able to download reports and summaries in html or pdf formats. If users generate tables or maps they are created in html and excel formats. The source of the data is clearly labeled and provided for each table/report. There is no indication on the website as to how often the data is updated.

A survey of women who obtained an abortion in the United States between June 2021 and July 2022 found that ** percent were Hispanic, while ** percent were white. This statistic shows the distribution of women in the U.S. who obtained an abortion from June 2021 to July 2022, by race/ethnicity.

The 1996 Uzbekistan Demographic and Health Survey (UDHS) is a nationally representative survey of 4,415 women age 15-49. Fieldwork was conducted from June to October 1996. The UDHS was sponsored by the Ministry of Health (MOH), and was funded by the United States Agency for International Development. The Institute of Obstetrics and Gynecology implemented the survey with technical assistance from the Demographic and Health Surveys (DHS) program. The 1996 UDHS was the first national-level population and health survey in Uzbekistan. It was implemented by the Research Institute of Obstetrics and Gynecology of the Ministry of Health of Uzbekistan. The 1996 UDHS was funded by the United States Agency for International development (USAID) and technical assistance was provided by Macro International Inc. (Calverton, Maryland USA) through its contract with USAID. OBJECTIVES AND ORGANIZATION OF THE SURVEY The purpose of the 1996 Uzbekistan Demographic and Health Survey (UDHS) was to provide an information base to the Ministry of Health for the planning of policies and programs regarding the health of women and their children. The UDHS collected data on women's reproductive histories, knowledge and use of contraception, breastfeeding practices, and the nutrition, vaccination coverage, and episodes of illness among children under the age of three. The survey also included, for all women of reproductive age and for children under the age of three, the measurement of the hemoglobin level in the blood to assess the prevalence of anemia and measurements of height and weight to assess nutritional status. A secondary objective of the survey was to enhance the capabilities of institutions in Uzbekistan to collect, process and analyze population and health data so as to facilitate the implementation of future surveys of this type. MAIN RESULTS Fertility Rates. Survey results indicate a total fertility rate (TFR) for all of Uzbekistan of 3.3 children per woman. Fertility levels differ for different population groups. The TFR for women living in urbml areas (2.7 children per woman) is substantially lower than for women living in rural areas (3.7). The TFR for Uzbeki women (3.5 children per woman) is higher than for women of other ethnicities (2.5). Among the regions of Uzbekistan, the TFR is lowest in Tashkent City (2.3 children per woman). Family Planning. Knowledge. Knowledge of contraceptive methods is high among women in Uzbekistan. Knowledge of at least one method is 89 percent. High levels of knowledge are the norm for women of all ages, all regions of the country, all educational levels, and all ethnicities. However, knowledge of sterilization was low; only 27 percent of women reported knowing of this method. Fertility Preferences. A majority of women in Uzbekistan (51 percent) indicated that they desire no more children. Among women age 30 and above, the proportion that want no more children increases to 75 percent. Thus, many women come to the preference to stop childbearing at relatively young ages when they have 20 or more potential years of childbearing ahead of them. For some of these women, the most appropriate method of contraception may be a long-acting method such as female sterilization, However, there is a deficiency of both knowledge and use of this method in Uzbekistan. In the interest of providing couples with a broad choice of safe and effective methods, information about this method and access to it should be made available so that informed choices about its suitability can be made by individual women and couples. Induced Aboration : Abortion Rates. From the UDHS data, the total abortion rate (TAR)the number of abortions a woman will have in her lifetime based on the currently prevailing abortion rateswas calculated. For Uzbekistan, the TAR for the period from mid-1993 to mid-1996 is 0.7 abortions per woman. As expected, the TAR for Uzbekistan is substantially lower than recent estimates of the TAR for other areas of the former Soviet Union such as Kazakstan (1.8), Romania (3.4 abortions per woman), and Yekaterinburg and Perm in Russia (2.3 and 2.8, respectively). Infant mortality : In the UDHS, infant mortality data were collected based on the international definition of a live birth which, irrespective of the duration of pregnancy, is a birth that breathes or shows any sign of life (United Nations, 1992). Mortality Rates. For the five-year period before the survey (i.e., approximately mid- 1992 to mid- 1996), infant mortality in Uzbekistan is estimated at 49 infant deaths per 1,000 births. The estimates of neonatal and postneonatal mortality are 23 and 26 per 1,000. Maternal and child health : Uzbekistan has a well-developed health system with an extensive infrastructure of facilities that provide maternal care services. This system includes special delivery hospitals, the obstetrics and gynecology departments of general hospitals, women's consulting centers, and doctor's assistant/midwife posts (FAPs). There is an extensive network of FAPs throughout rural areas. Nutrition : Breastfeeding. Breastfeeding is almost universal in Uzbekistan; 96 percent of children born in the three years preceding the survey are breastfed. Overall, 19 percent of children are breastfed within an hour of delivery and 40 percent within 24 hours of delivery. The median duration of breastfeeding is lengthy (17 months). However, durations of exclusive breastfeeding, as recommended by WHO, are short (0.4 months). Prevalence of anemia : Testing of women and children for anemia was one of the major efforts of the 1996 UDHS. Anemia has been considered a major public health problem in Uzbekistan for decades. Nevertheless, this was the first anemia study in Uzbekistan done on a national basis. The study involved hemoglobin (Hb) testing for anemia using the Hemocue system. Women. Sixty percent of the women in Uzbekistan suffer from some degree of anemia. The great majority of these women have either mild (45 percent) or moderate anemia (14 percent). One percent have severe anemia.

Abstract

The 1996 Uzbekistan Demographic and Health Survey (UDHS) is a nationally representative survey of 4,415 women age 15-49. Fieldwork was conducted from June to October 1996. The UDHS was sponsored by the Ministry of Health (MOH), and was funded by the United States Agency for International Development. The Institute of Obstetrics and Gynecology implemented the survey with technical assistance from the Demographic and Health Surveys (DHS) program.

The 1996 UDHS was the first national-level population and health survey in Uzbekistan. It was implemented by the Research Institute of Obstetrics and Gynecology of the Ministry of Health of Uzbekistan. The 1996 UDHS was funded by the United States Agency for International development (USAID) and technical assistance was provided by Macro International Inc. (Calverton, Maryland USA) through its contract with USAID.

OBJECTIVES AND ORGANIZATION OF THE SURVEY

The purpose of the 1996 Uzbekistan Demographic and Health Survey (UDHS) was to provide an information base to the Ministry of Health for the planning of policies and programs regarding the health of women and their children. The UDHS collected data on women's reproductive histories, knowledge and use of contraception, breastfeeding practices, and the nutrition, vaccination coverage, and episodes of illness among children under the age of three. The survey also included, for all women of reproductive age and for children under the age of three, the measurement of the hemoglobin level in the blood to assess the prevalence of anemia and measurements of height and weight to assess nutritional status.

A secondary objective of the survey was to enhance the capabilities of institutions in Uzbekistan to collect, process and analyze population and health data so as to facilitate the implementation of future surveys of this type.

MAIN RESULTS

• Fertility Rates. Survey results indicate a total fertility rate (TFR) for all of Uzbekistan of 3.3 children per woman. Fertility levels differ for different population groups. The TFR for women living in urbml areas (2.7 children per woman) is substantially lower than for women living in rural areas (3.7). The TFR for Uzbeki women (3.5 children per woman) is higher than for women of other ethnicities (2.5). Among the regions of Uzbekistan, the TFR is lowest in Tashkent City (2.3 children per woman).
• Family Planning. Knowledge. Knowledge of contraceptive methods is high among women in Uzbekistan. Knowledge of at least one method is 89 percent. High levels of knowledge are the norm for women of all ages, all regions of the country, all educational levels, and all ethnicities. However, knowledge of sterilization was low; only 27 percent of women reported knowing of this method.
• Fertility Preferences. A majority of women in Uzbekistan (51 percent) indicated that they desire no more children. Among women age 30 and above, the proportion that want no more children increases to 75 percent. Thus, many women come to the preference to stop childbearing at relatively young ages when they have 20 or more potential years of childbearing ahead of them. For some of these women, the most appropriate method of contraception may be a long-acting method such as female sterilization, However, there is a deficiency of both knowledge and use of this method in Uzbekistan. In the interest of providing couples with a broad choice of safe and effective methods, information about this method and access to it should be made available so that informed choices about its suitability can be made by individual women and couples.
• Induced Aboration : Abortion Rates. From the UDHS data, the total abortion rate (TAR)--the number of abortions a woman will have in her lifetime based on the currently prevailing abortion rates--was calculated. For Uzbekistan, the TAR for the period from mid-1993 to mid-1996 is 0.7 abortions per woman. As expected, the TAR for Uzbekistan is substantially lower than recent estimates of the TAR for other areas of the former Soviet Union such as Kazakstan (1.8), Romania (3.4 abortions per woman), and Yekaterinburg and Perm in Russia (2.3 and 2.8, respectively).
• Infant mortality : In the UDHS, infant mortality data were collected based on the international definition of a live birth which, irrespective of the duration of pregnancy, is a birth that breathes or shows any sign of life (United Nations, 1992).
• Mortality Rates. For the five-year period before the survey (i.e., approximately mid- 1992 to mid- 1996), infant mortality in Uzbekistan is estimated at 49 infant deaths per 1,000 births. The estimates of neonatal and postneonatal mortality are 23 and 26 per 1,000.
• Maternal and child health : Uzbekistan has a well-developed health system with an extensive infrastructure of facilities that provide maternal care services. This system includes special delivery hospitals, the obstetrics and gynecology departments of general hospitals, women's consulting centers, and doctor's assistant/midwife posts (FAPs). There is an extensive network of FAPs throughout rural areas.
• Nutrition : Breastfeeding. Breastfeeding is almost universal in Uzbekistan; 96 percent of children born in the three years preceding the survey are breastfed. Overall, 19 percent of children are breastfed within an hour of delivery and 40 percent within 24 hours of delivery. The median duration of breastfeeding is lengthy (17 months). However, durations of exclusive breastfeeding, as recommended by WHO, are short (0.4 months).
• Prevalence of anemia : Testing of women and children for anemia was one of the major efforts of the 1996 UDHS. Anemia has been considered a major public health problem in Uzbekistan for decades. Nevertheless, this was the first anemia study in Uzbekistan done on a national basis. The study involved hemoglobin (Hb) testing for anemia using the Hemocue system. Women. Sixty percent of the women in Uzbekistan suffer from some degree of anemia. The great majority of these women have either mild (45 percent) or moderate anemia (14 percent). One percent have severe anemia.

Geographic coverage

National Seven raions were excluded from the survey because they were considered too remote and sparsely inhabited.

Analysis unit

• Household
• Women age 15-49

Universe

The population covered by the 1996 UDHS is defined as the universe of all women age 15-49 in Uzbekistan

Kind of data

Sample survey data

Sampling procedure

The UDHS employed a probability sample of women age 15 to 49, representative of 98.7 percent of the country. Seven raions were excluded from the survey because they were considered too remote and sparsely inhabited. These raions are: Kungradskiyi, Muyinakskiyi, and Takhtakupyrskiyi in Karakalpakstan; Uchkudukskiyi, Tamdynskiyi, and Kanimekhskiyi in Navoiiskaya; and Romitanskiyi in Bukharskaya. The remainder of the country was divided into five survey regions. Tashkent City constituted a survey region by itself, while the remaining four survey regions consisted of groups of contiguous oblasts. The five survey regions were defined as follows: Region 1: Karakalpakstan and Khoresmskaya. Region 2: Navoiyiskaya, Bukharskaya, Kashkadarinskaya, and Surkhandarinskaya. Region 3: Samarkandskaya, Dzhizakskaya, Syrdarinskaya, and Tashkentskaya. Region 4: Namanganskaya, Ferganskaya, and Andizhanskaya. Region 5: Tashkent City.

CHARACTERISTICS OF THE UDHS SAMPLE

The sample for the UDHS was selected in three stages. In the rural areas, the primary sampling units (PSUs) corresponded to the raions which were selected with probabilities proportional to size, the size being the 1994 population. At the second stage, one village was selected in each selected raion. A complete listing of the households residing in each selected village was carried out. The lists of households obtained were used as the frame for third-stage sampling, which is the selection of the households to be visited by the UDHS interviewing teams during the main survey fieldwork. In each selected household, women between the ages of 15 and 49 were identified and interviewed.

In the urban areas, the PSUs were the cities and towns themselves. In the second stage, one health block was selected from each town except in self-representing cities (large cities that were selected with certainty), where more than one health block was selected. The selected health blocks were segmented prior to the household listing operation which provided the household lists for the third-stage selection of households.

SAMPLE ALLOCATION

The regions, stratified by urban and rural areas, were the sampling strata. There were thus nine strata with Tashkent City constituting an entire stratum. A proportional allocation of the target number of 4,000 women to the 9 strata would yield the sample distribution.

The proportional allocation would result in a completely self-weighting sample but would not allow for reliable estimates for at least two of the five survey regions, namely Region 1 and Tashkent City. Results of other demographic and health surveys show that a minimum sample of 1,000 women is required in order to obtain estimates of fertility and childhood mortality rates at an acceptable level of sampling errors. Given that the total sample size for the UDHS could not he increased so as to achieve the required level of sampling errors, it was decided that the sample would be divided equally among the five regions, and within each region, it would be distributed proportionally to the urban and the rural areas. With this type of allocation, demographic rates (fertility and mortality) could not be produced for regions separately.

The number of sample points (or clusters) to be selected for each stratum was calculated by dividing the

BackgroundIn February 2011, an Ohio law took effect mandating use of the United States Food and Drug Administration (FDA)-approved protocol for mifepristone, which is used with misoprostol for medication abortion. Other state legislatures have passed or enacted similar laws requiring use of the FDA-approved protocol for medication abortion. The objective of this study is to examine the association of this legal change with medication abortion outcomes and utilization.Methods and FindingsWe used a retrospective cohort design, comparing outcomes of medication abortion patients in the prelaw period to those in the postlaw period. Sociodemographic and clinical chart data were abstracted from all medication abortion patients from 1 y prior to the law’s implementation (January 2010–January 2011) to 3 y post implementation (February 2011–October 2014) at four abortion-providing health care facilities in Ohio. Outcome data were analyzed for all women undergoing abortion at ≤49 d gestation during the study period. The main outcomes were as follows: need for additional intervention following medication abortion (such as aspiration, repeat misoprostol, and blood transfusion), frequency of continuing pregnancy, reports of side effects, and the proportion of abortions that were medication abortions (versus other abortion procedures). Among the 2,783 medication abortions ≤49 d gestation, 4.9% (95% CI: 3.7%–6.2%) in the prelaw and 14.3% (95% CI: 12.6%–16.0%) in the postlaw period required one or more additional interventions. Women obtaining a medication abortion in the postlaw period had three times the odds of requiring an additional intervention as women in the prelaw period (adjusted odds ratio [AOR] = 3.11, 95% CI: 2.27–4.27). In a mixed effects multivariable model that uses facility-months as the unit of analysis to account for lack of independence by site, we found that the law change was associated with a 9.4% (95% CI: 4.0%–18.4%) absolute increase in the rate of requiring an additional intervention. The most common subsequent intervention in both periods was an additional misoprostol dose and was most commonly administered to treat incomplete abortion. The percentage of women requiring two or more follow-up visits increased from 4.2% (95% CI: 3.0%–5.3%) in the prelaw period to 6.2% (95% CI: 5.5%–8.0%) in the postlaw period (p = 0.003). Continuing pregnancy was rare (0.3%). Overall, 12.6% of women reported at least one side effect during their medication abortion: 8.4% (95% CI: 6.8%–10.0%) in the prelaw period and 15.6% (95% CI: 13.8%–17.3%) in the postlaw period (p < 0.001). Medication abortions fell from 22% (95% CI: 20.8%–22.3%) of all abortions the year before the law went into effect (2010) to 5% (95% CI: 4.8%–5.6%) 3 y after (2014) (p < 0.001). The average patient charge increased from US$426 in 2010 to US$551 in 2014, representing a 16% increase after adjusting for inflation in medical prices. The primary limitation to the study is that it was a pre/post-observational study with no control group that was not exposed to the law.ConclusionsOhio law required use of a medication abortion protocol that is associated with a greater need for additional intervention, more visits, more side effects, and higher costs for women relative to the evidence-based protocol. There is no evidence that the change in law led to improved abortion outcomes. Indeed, our findings suggest the opposite. In March 2016, the FDA-protocol was updated, so Ohio providers may now legally provide current evidence-based protocols. However, this law is still in place and bans physicians from using mifepristone based on any new developments in clinical research as best practices continue to be updated.

The number of abortion-related deaths in the U.S. has decreased dramatically since 1973. In 1973, the number of deaths related to abortions was 47. In 2021, the number of reported deaths related to abortions had decreased to just five. Abortion is the act of ending a pregnancy so that it does not result in the birth of a baby. Abortions in the U.S. Abortions can be performed in a surgical setting or a medical setting (the pill). The number of legal abortions reported in the U.S. has generally declined yearly since 1990. The most frequently performed kind of abortion in the U.S. in 2022 were medical abortions. Abortion and the legality and morality of the procedure has been a publicly debated topic in the United States for many years. Public opinions on abortion Opinions on abortion in the United States can be divided into two campaigns. Pro-choice is the belief that women have the right to decide when they want to become pregnant and if they want to terminate the pregnancy through an abortion. Pro-life, is the belief that women should not be able to choose to have an abortion. As of 2023, around 52 percent of the U.S. population was pro-choice, while 44 percent considered themselves pro-life. However, these shares have fluctuated over the past couple decades, with a majority of people saying they were pro-life as recently as 2019.

There is evidence from the United States that the legalisation of abortion has led to a significant reduction in neonatal and infant mortality. However, no research to date has been able to disentangle between effects of improved access to abortion at the household- and cohort-levels; there is no evidence for developing countries; and existing studies of the impact of abortion legalisation on early life health in the United States are not unanimous. Nepal initiated a drastic abortion reform in 2002. Moreover, because abortion facilities were made available to the public, the change in the law was not purely de jure. This research will collect data on local availability of abortion services, which opened at different times over a two-year period across the country. Combined with existing data sources, this information will allow estimating the effect of improved access to abortion more precisely, holding constant a number of potentially confounding factors. It will also compare neonatal mortality occurrence between siblings born before and those born after the opening of a nearby legal abortion centre, compare the effect on boys and girls, and estimate whether there is any evidence of improved access to abortion leading to sex-selective abortions.

Abstract

The Ukraine Demographic and Health Survey (UDHS) is a nationally representative survey of 6,841 women age 15-49 and 3,178 men age 15-49. Survey fieldwork was conducted during the period July through November 2007. The UDHS was conducted by the Ukrainian Center for Social Reforms in close collaboration with the State Statistical Committee of Ukraine. The MEASURE DHS Project provided technical support for the survey. The U.S. Agency for International Development/Kyiv Regional Mission to Ukraine, Moldova, and Belarus provided funding.

The survey is a nationally representative sample survey designed to provide information on population and health issues in Ukraine. The primary goal of the survey was to develop a single integrated set of demographic and health data for the population of the Ukraine.

The UDHS was conducted from July to November 2007 by the Ukrainian Center for Social Reforms (UCSR) in close collaboration with the State Statistical Committee (SSC) of Ukraine, which provided organizational and methodological support. Macro International Inc. provided technical assistance for the survey through the MEASURE DHS project. USAID/Kyiv Regional Mission to Ukraine, Moldova and Belarus provided funding for the survey through the MEASURE DHS project. MEASURE DHS is sponsored by the United States Agency for International Development (USAID) to assist countries worldwide in obtaining information on key population and health indicators.

The 2007 UDHS collected national- and regional-level data on fertility and contraceptive use, maternal health, adult health and life style, infant and child mortality, tuberculosis, and HIV/AIDS and other sexually transmitted diseases. The survey obtained detailed information on these issues from women of reproductive age and, on certain topics, from men as well.

The results of the 2007 UDHS are intended to provide the information needed to evaluate existing social programs and to design new strategies for improving the health of Ukrainians and health services for the people of Ukraine. The 2007 UDHS also contributes to the growing international database on demographic and health-related variables.

MAIN RESULTS

• Fertility rates. A useful index of the level of fertility is the total fertility rate (TFR), which indicates the number of children a woman would have if she passed through the childbearing ages at the current age-specific fertility rates (ASFR). The TFR, estimated for the three-year period preceding the survey, is 1.2 children per woman. This is below replacement level.

• Contraception : Knowledge and ever use. Knowledge of contraception is widespread in Ukraine. Among married women, knowledge of at least one method is universal (99 percent). On average, married women reported knowledge of seven methods of contraception. Eighty-nine percent of married women have used a method of contraception at some time.

• Abortion rates. The use of abortion can be measured by the total abortion rate (TAR), which indicates the number of abortions a woman would have in her lifetime if she passed through her childbearing years at the current age-specific abortion rates. The UDHS estimate of the TAR indicates that a woman in Ukraine will have an average of 0.4 abortions during her lifetime. This rate is considerably lower than the comparable rate in the 1999 Ukraine Reproductive Health Survey (URHS) of 1.6. Despite this decline, among pregnancies ending in the three years preceding the survey, one in four pregnancies (25 percent) ended in an induced abortion.

• Antenatal care. Ukraine has a well-developed health system with an extensive infrastructure of facilities that provide maternal care services. Overall, the levels of antenatal care and delivery assistance are high. Virtually all mothers receive antenatal care from professional health providers (doctors, nurses, and midwives) with negligible differences between urban and rural areas. Seventy-five percent of pregnant women have six or more antenatal care visits; 27 percent have 15 or more ANC visits. The percentage is slightly higher in rural areas than in urban areas (78 percent compared with 73 percent). However, a smaller proportion of rural women than urban women have 15 or more antenatal care visits (23 percent and 29 percent, respectively).

• HIV/AIDS and other sexually transmitted infections : The currently low level of HIV infection in Ukraine provides a unique window of opportunity for early targeted interventions to prevent further spread of the disease. However, the increases in the cumulative incidence of HIV infection suggest that this window of opportunity is rapidly closing.

• Adult Health : The major causes of death in Ukraine are similar to those in industrialized countries (cardiovascular diseases, cancer, and accidents), but there is also a rising incidence of certain infectious diseases, such as multidrug-resistant tuberculosis.

• Women's status : Sixty-four percent of married women make decisions on their own about their own health care, 33 percent decide jointly with their husband/partner, and 1 percent say that their husband or someone else is the primary decisionmaker about the woman's own health care.

• Domestic Violence : Overall, 17 percent of women age 15-49 experienced some type of physical violence between age 15 and the time of the survey. Nine percent of all women experienced at least one episode of violence in the 12 months preceding the survey. One percent of the women said they had often been subjected to violent physical acts during the past year. Overall, the data indicate that husbands are the main perpetrators of physical violence against women.

• Human Trafficking : The UDHS collected information on respondents' awareness of human trafficking in Ukraine and, if applicable, knowledge about any household members who had been the victim of human trafficking during the three years preceding the survey. More than half (52 percent) of respondents to the household questionnaire reported that they had heard of a person experiencing this problem and 10 percent reported that they knew personally someone who had experienced human trafficking.

Geographic coverage

The survey is a nationally representative sample survey designed to provide information on population and health issues in Ukraine. The 27 administrative regions were grouped for this survey into five geographic regions: North, Central, East, South and West. The five geographic regions are the five study domains of the survey. The estimates obtained from the 2007 UDHS are presented for the country as a whole, for urban and rural areas, and for each of the five geographic regions.

Analysis unit

• Household
• Women age 15-49
• Men age 15-49

Universe

The population covered by the 2007 UDHS is defined as the universe of all women and men age 15-49 in Ukraine.

Kind of data

Sample survey data

Sampling procedure

The 2007 Ukraine Demographic and Health Survey (UDHS) was the first survey of its kind carried out in Ukraine. The survey was a nationally representative sample survey of 15,000 households, with an expected yield of about 7,900 completed interviews of women age 15-49. It was designed to provide estimates on fertility, infant and child mortality, use of contraception and family planning, knowledge and attitudes toward HIV/AIDS and other sexually transmitted infections (STI), and other family welfare and health indicators. Ukraine is made up of 24 oblasts, the Autonomous Republic of Crimea, and two special cities (Kyiv and Sevastopol), which together make up 27 administrative regions, each subdivided into lower-level administrative units. The 27 administrative regions were grouped for this survey into five geographic regions: North, Central, East, South and West. The five geographic regions are the five study domains of the survey. The estimates obtained from the 2007 UDHS are presented for the country as a whole, for urban and rural areas, and for each of the five geographic regions.

A men's survey was conducted at the same time as the women's survey, in a subsample consisting of one household in every two selected for the female survey. All men age 15-49 living in the selected households were eligible for the men's survey. The survey collected information on men's use of contraception and family planning and their knowledge and attitudes toward HIV/AIDS and other sexually transmitted infections (STI).

SAMPLING FRAME

The sampling frame used for the 2007 UDHS was the Ukraine Population Census conducted in 2001 (SSC, 2003a), provided by the State Statistical Committee (SSC) of Ukraine. The sampling frame consisted of about 38 thousand enumeration areas (EAs) with an average of 400-500 households per EA. Each EA is subdivided into 4-5 enumeration units (EUs) with an average of 100 households per EU. An EA is a city block in urban areas; in rural areas, an EA is either a village or part of a large village, or a group of small villages (possibly plus a part of a large village). An EU is a list of addresses (in a neighborhood) that was used as a convenient counting unit for the census. Both EAs and EUs include information about the location, type of residence, address of each structure in it, and the number of households in each structure.

Census maps were available for most of the EAs with marked boundaries. In urban areas, the census maps have marked boundaries/locations of the EUs. In rural areas, the EUs are defined by detailed descriptions available at the SSC local office. Therefore, either the EA or the EU could be used as the primary sampling unit (PSU) for the 2007 UDHS. Because the EAs in urban areas are large (an average of 500 households), using

cvs AED+971552965071 abortion pills in dubai Abu Dhabi Cytotec Plllz In Abu Dhabi Dubai al satwa misoprostol ⋐⋑ UAEDUBAISHARJAHAL AINRAKFUJAIRAHUAQAJMANDUBAI cytotec @#Abortion Pills in Abu Dhabi Ajman COMBIPACK MIFEPRISTONE Misoprostol and Misoprostol pills for sale in Dubai WhatsAPP, Abu Dhabi, Sharjah. 100^%)( UAE).(((WhatsAPP)).%%&^())௹ )Abortion Pills for Sale in Dubai. Abu Dhabi. UAE DUBAI | SHARJAH |AJMAN | Qurum Beach Bimmah Sinkhole City Centre Muscat Sultan Qaboos Grand Mosque Bait Al Zubair Royal Opera House Muscat Daymaniyat Islands Snorkeling Sharing Trip Historical Muscat Sunset Tour Nizwa Al Mouj Muscat Aloft Muscat Muscat Grand Mall Yitti Beach Al Alam Palace Al Amarat Al Azaiba South Al Jalali Fort Al Khuwair Street Al Mawaleh South Crowne Plaza Muscat, an IHG Hotel Hajjar mountains Madinat Al Sultan Qaboos Mutrah Corniche Boush 100^%)( UAE).(((WhatsAPP)).%%&^())௹ )Abortion Pills for Sale in Dubai. Abu Dhabi. UAE DUBAI | SHARJAH |AJMAN | ABU DHABI | To AL AIN | UAE$%$ : Cytotec In DUBAI in dubai uae(((☎️({[+}}) ))))@UAE@ Safe Abortion Pills For Sale in Dubai,#☎️ wsp) #Abortion medicine For sale in #ABU DHABI #UAE ##DUBAI? FUJAIRAH? ##SHARJAH? #AJMAN? #AL AIN? UAE? IN ABU DHABI In dubai WhatsApp ({[}}) _ Abortion Pills In dubai))((misoprostol&cytotec available in dubai,abortion pills for sale in dubai Abortion pills For sale in Dubai,Dhabi/Alain/Sharjah/RAK city Satwa-mifepristone & Misoprostol Available in Dubai/Abu Dhabi-ipills in Dubai & Cost of Cytotec in WhatsAppsad{[+}}) Abortion Pills in Dubai/Abu Dubai/Abu Dhabi. WhatsApp: ({[}}) : ({[}}) Are you stranded with unwanted pregnancy in Dubai, Abu Dhabi, the United Arab Emirates(UAE), Qatar, Oman Saudi Arabia or Kuwait? , you can now contact us now on whatsapp Dr. Mayasad{[}}) to buy safe abortion pills In Dubai, Abu Dhabi, Sharjah, Al Ain, Ajman, RAK City, Ras Al Khaimah and Fujairah to terminate an unwanted pregnancy in Dubai and the United Arab Emirates, Get your discreet 100% safe({[}}) effective abortion pills For sale in Dubai,Abu Dhabi,KUWAIT,QATAR,BAHRAIN, DOHA,SALMIYA,Sharjah,Ajman, Alain, Fujairah, Ras Al Khaimah, Umm Al Quwain, UAE. BUY Mifepristone and Misoprostol (Cytotec), Mtp Kit In UAE. Abortion pills available in UAE (United Arab Emirates), Saudi Arabia, Kuwait, Oman, Bahrain and Qatar. Contact us today.({[}}) -The UAE's leading abortion care service in Dubai. Abortion Treatment. Medical Abortion. Surgical Abortion. Find A Clinic like Dr. MayaAbortion clinic in Dubai We have Abortion Pills / Cytotec Tablets Available in Dubai,AbuDhabi, KUWAIT, QATAR, BAHRAIN, DOHA,SALMIYA,Sharjah, Ajman, Alain, Fujairah, Ras Al Khaimah, Umm Al Quwain, UAE ., buy cytotec in Dubai abortion Pills Cytotec also available Oman Qatar Doha Saudi Arabia Bahrain We sell original abortion medicine which includes: Cytotec 200mcg (Misoprostol), Mifepristone, Mifegest-kit, Misoclear, Emergency contraceptive pills, Morning after sex pills, ipills, pills to prevent pregnancy 72 hours after sex. All our pills are manufactured by reputable medical manufacturing companies like FDA and PFIZER. Medical abortion is easy and effective for everyone to perform on their own privacy. There are very few complications that may arise from medical abortion if one follows the right guidelines as instructed by the obstetrician. Abortion Pills in Dubai Can Now Be Offered at Dr. MayaAbortion clinic in Dubai, FDA Says Mifepristone and Misoprostol, the first of two drugs in medication abortions, previously had to be dispensed only by clinics, doctors or a few mail-order pharmacies like Dr Maya Abortion clinic in Dubai. Now, We can provide it. For the first time, retail pharmacies, like Dr. Donam Abortion clinic in Dubai, will be able to offer abortion pills in Dubai under a regulatory change made Tuesday by the Food and Drug Administration. @@@#Abortion Pills For sale In DUBAI#@UAE@#☎️##Safe Abortion Pills in Dubai,#☎️ wsp({[}}) )# UNITED ARAB EMIRATES@, FUJAIRAH,# ABU DHABI# UAE #Oman,#Bahrain, @Qatar,Abu Dhabi@,Sharjah,@Ajman@,fujairah@Kuwait@Buy abortion pills IN DUBAI@?? Where to buy(({[}}) ) Abortion Pills in Dubai/UAE/ Abudhabi/Fujairah wsp({[}}) ))-mifepristone & misoprostol in Dubai /Abu Dhabi/Sharjah- price of cytotec in Dubai/Ajman/RAK-Abortion pills for sale in DUBAIDubai / UAEDubai / UAE#@@ABORTION PILLS FOR SALE IN DUBAI,#SHARJAH, #ABU DHABI,# AJMAN#, AL AIN, # AL BARSHA# DUBAI,# Fujairah, #Ras Al Khaimah,# Rak City3#ABORTION PILLS FOR SALE IN SHARJAH#, ABU DHABI,# AJMAN#, AL AIN,# AL BARSHA# Globally millions have ended unwanted their pregnancies using cytotec 200mcg ### Abortion Pills For Sale In Dubai, Abu Dhabi, Sharjah, Al Ain, Ajman, Ras Al Khaimah, Fujairah #Women's Clinic In Dubai

Abu Dhabi cytotec pills/tablets ☎️⁉️ +971552965071 }} DUBAI cytotec @#Abortion Pills in Abu Dhabi Ajman COMBIPACK MIFEPRISTONE Misoprostol and Misoprostol pills for sale in Dubai WhatsAPP, Abu Dhabi, Sharjah. 100^%)( UAE).(((WhatsAPP)).%%&^())௹ )Abortion Pills for Sale in Dubai. Abu Dhabi. UAE DUBAI | SHARJAH |AJMAN | Qurum Beach Bimmah Sinkhole City Centre Muscat Sultan Qaboos Grand Mosque Bait Al Zubair Royal Opera House Muscat Daymaniyat Islands Snorkeling Sharing Trip Historical Muscat Sunset Tour Nizwa Al Mouj Muscat Aloft Muscat Muscat Grand Mall Yitti Beach Al Alam Palace Al Amarat Al Azaiba South Al Jalali Fort Al Khuwair Street Al Mawaleh South Crowne Plaza Muscat, an IHG Hotel Hajjar mountains Madinat Al Sultan Qaboos Mutrah Corniche Boush 100^%)( UAE).(((WhatsAPP)).%%&^())௹ )Abortion Pills for Sale in Dubai. Abu Dhabi. UAE DUBAI | SHARJAH |AJMAN | ABU DHABI | To AL AIN | UAE$%$ : Cytotec In DUBAI in dubai uae(((☎️({[+}}) ))))@UAE@ Safe Abortion Pills For Sale in Dubai,#☎️ wsp) #Abortion medicine For sale in #ABU DHABI #UAE ##DUBAI? FUJAIRAH? ##SHARJAH? #AJMAN? #AL AIN? UAE? IN ABU DHABI In dubai WhatsApp ({[}}) _ Abortion Pills In dubai))((misoprostol&cytotec available in dubai,abortion pills for sale in dubai Abortion pills For sale in Dubai,Dhabi/Alain/Sharjah/RAK city Satwa-mifepristone & Misoprostol Available in Dubai/Abu Dhabi-ipills in Dubai & Cost of Cytotec in WhatsAppsad{[+}}) Abortion Pills in Dubai/Abu Dubai/Abu Dhabi. WhatsApp: ({[}}) : ({[}}) Are you stranded with unwanted pregnancy in Dubai, Abu Dhabi, the United Arab Emirates(UAE), Qatar, Oman Saudi Arabia or Kuwait? , you can now contact us now on whatsapp Dr. Mayasad{[}}) to buy safe abortion pills In Dubai, Abu Dhabi, Sharjah, Al Ain, Ajman, RAK City, Ras Al Khaimah and Fujairah to terminate an unwanted pregnancy in Dubai and the United Arab Emirates, Get your discreet 100% safe({[}}) effective abortion pills For sale in Dubai,Abu Dhabi,KUWAIT,QATAR,BAHRAIN, DOHA,SALMIYA,Sharjah,Ajman, Alain, Fujairah, Ras Al Khaimah, Umm Al Quwain, UAE. BUY Mifepristone and Misoprostol (Cytotec), Mtp Kit In UAE. Abortion pills available in UAE (United Arab Emirates), Saudi Arabia, Kuwait, Oman, Bahrain and Qatar. Contact us today.({[}}) -The UAE's leading abortion care service in Dubai. Abortion Treatment. Medical Abortion. Surgical Abortion. Find A Clinic like Dr. MayaAbortion clinic in Dubai We have Abortion Pills / Cytotec Tablets Available in Dubai,AbuDhabi, KUWAIT, QATAR, BAHRAIN, DOHA,SALMIYA,Sharjah, Ajman, Alain, Fujairah, Ras Al Khaimah, Umm Al Quwain, UAE ., buy cytotec in Dubai abortion Pills Cytotec also available Oman Qatar Doha Saudi Arabia Bahrain We sell original abortion medicine which includes: Cytotec 200mcg (Misoprostol), Mifepristone, Mifegest-kit, Misoclear, Emergency contraceptive pills, Morning after sex pills, ipills, pills to prevent pregnancy 72 hours after sex. All our pills are manufactured by reputable medical manufacturing companies like FDA and PFIZER. Medical abortion is easy and effective for everyone to perform on their own privacy. There are very few complications that may arise from medical abortion if one follows the right guidelines as instructed by the obstetrician. Abortion Pills in Dubai Can Now Be Offered at Dr. MayaAbortion clinic in Dubai, FDA Says Mifepristone and Misoprostol, the first of two drugs in medication abortions, previously had to be dispensed only by clinics, doctors or a few mail-order pharmacies like Dr Maya Abortion clinic in Dubai. Now, We can provide it. For the first time, retail pharmacies, like Dr. Donam Abortion clinic in Dubai, will be able to offer abortion pills in Dubai under a regulatory change made Tuesday by the Food and Drug Administration. @@@#Abortion Pills For sale In DUBAI#@UAE@#☎️##Safe Abortion Pills in Dubai,#☎️ wsp({[}}) )# UNITED ARAB EMIRATES@, FUJAIRAH,# ABU DHABI# UAE #Oman,#Bahrain, @Qatar,Abu Dhabi@,Sharjah,@Ajman@,fujairah@Kuwait@Buy abortion pills IN DUBAI@?? Where to buy(({[}}) ) Abortion Pills in Dubai/UAE/ Abudhabi/Fujairah wsp({[}}) ))-mifepristone & misoprostol in Dubai /Abu Dhabi/Sharjah- price of cytotec in Dubai/Ajman/RAK-Abortion pills for sale in DUBAIDubai / UAEDubai / UAE#@@ABORTION PILLS FOR SALE IN DUBAI,#SHARJAH, #ABU DHABI,# AJMAN#, AL AIN, # AL BARSHA# DUBAI,# Fujairah, #Ras Al Khaimah,# Rak City3#ABORTION PILLS FOR SALE IN SHARJAH#, ABU DHABI,# AJMAN#, AL AIN,# AL BARSHA# Globally millions have ended unwanted their pregnancies using cytotec 200mcg ### Abortion Pills For Sale In Dubai, Abu Dhabi, Sharjah, Al Ain, Ajman, Ras Al Khaimah, Fujairah #Women's Clinic In Dubai